These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3081830)

  • 1. Function of dopamine receptors in Parkinson's disease: prolactin responses.
    Laihinen A; Rinne UK
    Neurology; 1986 Mar; 36(3):393-5. PubMed ID: 3081830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin secretion in Parkinson disease.
    Eisler T; Thorner MO; MacLeod RM; Kaiser DL; Calne DB
    Neurology; 1981 Oct; 31(10):1356-9. PubMed ID: 6810204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of dopamine receptors in young-onset Parkinson's disease: prolactin response.
    Kostic VS; Marinkovic Z; Filipovic S; Momcilovic D
    Mov Disord; 1993 Apr; 8(2):227-9. PubMed ID: 8474497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium channel blockade with verapamil on the prolactin responses to TRH, L-dopa, and bromocriptine.
    Kamal TJ; Molitch ME
    Am J Med Sci; 1992 Nov; 304(5):289-93. PubMed ID: 1332473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain receptor changes in Parkinson's disease in relation to the disease process and treatment.
    Rinne UK; Rinne JO; Rinne JK; Laakso K; Laihinen A; Lönnberg P
    J Neural Transm Suppl; 1983; 18():279-86. PubMed ID: 6308149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M; Yamaji T
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolactin response as an index of dopaminergic receptor function in Parkinson's disease. Correlation with clinical findings and therapeutic response.
    Agnoli A; Baldassarre M; Ruggieri S; Falaschi P; Urso RD; Rocco A
    J Neural Transm; 1981; 51(1-2):123-34. PubMed ID: 7264625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Patients with Parkinson disease: functional analysis of dopamine receptors by bromocriptine- thyrotropin-releasing hormone test].
    Díaz F; Liberman C; Chariá P
    Rev Med Chil; 1991 Mar; 119(3):252-7. PubMed ID: 1842116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does bromocriptine block thyrotropin-releasing hormone-induced prolactin release during pregnancy?
    Ylikorkala O; Kivinen S; Rönnberg L; Viinikka L
    J Clin Endocrinol Metab; 1980 Mar; 50(3):600-2. PubMed ID: 6766949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patients.
    Cusimano G; Capriani C; Bonifati V; Meco G
    Acta Neurol Scand; 1991 Mar; 83(3):145-50. PubMed ID: 1903236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroendocrine correlations in the pathogenesis and pathology of Parkinson disease].
    Pinessi L; Sabbatini F; De Mattei M; Gentile S
    Minerva Med; 1984 Nov; 75(42):2539-42. PubMed ID: 6096765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The extracerebral dopamine antagonist domperidone block the suppressive effect of bromocriptine on prolactin and TSH secretion in man.
    Svet-Moldavsky I; Svet-Moldavsky G; Zinzar S; Holland J; Vergara C; Arlin Z; Koziner B; Clarkson B
    Biomedicine; 1981 Oct; 35(5):142-4. PubMed ID: 6797487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRH test and the continuous dopaminergic stimulation in complicated Parkinson's disease.
    Lestingi L; Bonifati V; Stocchi F; Antonozzi I; Meco G
    Eur Neurol; 1992; 32(2):65-9. PubMed ID: 1563463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine.
    Hirvonen E; Ranta T; Seppäla M
    J Clin Endocrinol Metab; 1976 Jun; 42(6):1024-30. PubMed ID: 819453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of bromocriptine, dopamine, and thyrotropin-releasing hormone to affect prolactin secretion by human decidual tissue in vitro.
    Golander A; Barrett J; Hurley T; Barry S; Handwerger S
    J Clin Endocrinol Metab; 1979 Nov; 49(5):787-9. PubMed ID: 114530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catecholamines and pituitary function. III. Restoration of the prolactin response to thyrotropin-releasing hormone by low-dose dopamine infusion in women with pathological hyperprolactinemia.
    Nicoletti I; Filipponi P; Fedeli L; Sfrappini M; Gregorini G; Ambrosi F; Santeusanio F
    Horm Res; 1984; 20(3):202-12. PubMed ID: 6436160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of transient dopamine antagonism on thyrotropin-releasing hormone-induced prolactin release in pseudopregnant rats.
    Haisenleder DJ; Moy JA; Gala RR; Lawson DM
    Endocrinology; 1986 Nov; 119(5):1989-95. PubMed ID: 3095097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine receptor function in Parkinson's disease--in vivo studies with prolactin responses.
    Laihinen A; Rinne UK
    Adv Neurol; 1987; 45():249-52. PubMed ID: 3103387
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions.
    Jaquet P; Gunz G; Grisoli F
    Horm Res; 1985; 22(3):153-63. PubMed ID: 3932176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prolactin-releasing mechanism of the hypothalamo-pituitary axis in pregnancy.
    Kubota T; Yaoi Y; Nagae M; Kumasaka T; Saito M
    Fertil Steril; 1984 Nov; 42(5):724-9. PubMed ID: 6436068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.